Cost-Effectiveness Analysis of Alectinib Compared To Chemotherapy for The Treatment of Treatment-Naïve Patients With Alk Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) in Greece
Abstract
Authors
N Kourkoulas D Kyriopoulos K Athanasakis